In a decision with implications for biotechnology licensing and pharmaceutical manufacturing, the Ninth Circuit has rejected a ‘sweeping’ royalty trigger from a lower court. Already registered?

As the US Supreme Court prepares to hear arguments in the Hikma and Amarin dispute, the case has drawn a broad coalition of ...

The Danish company is contending with fierce competition, a clinical trial setback and a UK boost to its main rival, while ...

The New York hire brings broad litigation and transactional experience, including advising clients on artificial intelligence, biotech, pharma and chemical matters. If you don't have a login or your ...

A new study suggests the equipment already found in hospitals worldwide could offer a front line against fake vaccines and insulin. If you don't have a login or your access has expired, you will need ...